For funds, family offices, and lenders who want a clear view of regulatory and legal risk in healthcare deals and portfolios.
01
A focused, healthcare-specific review of the target’s licenses, key contracts, employment arrangements, and known or undisclosed disputes, structured to surface value-affecting risk before closing.
02
Systematic scoring of risk exposure across four dimensions: licensing compliance, HR and employment structure, patient safety obligations, and supply chain and procurement arrangements.
03
Advisory on regulatory conditions precedent, deal warranties and undertakings, representation language, and remediation timelines, aligned with the specific regulatory environment of the target.
04
Structured 90-day remediation plans to address identified gaps, paired with periodic portfolio health checks to track compliance progress and flag emerging regulatory exposure.
